The observed trends in GLP‐1 could reflect a unifying mechanism explaining hypoaminoacidemia, aminoaciduria, and predisposition to DM in ACHES, and an additional diagnostic or therapeutic target. This evidence concerns the gene GCG and diabetes mellitus.